Inactive Instrument
Ark Therapeutics Group plc Stock London S.E.
Stocks
GB0034251727
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| Market Cap | 5.29M 7.02M 6.13M 5.67M 9.94M 663M 10.01M 67.41M 26.23M 326M 26.35M 25.78M 1.13B | P/E 2024 |
1.51x | P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | -9.39M -12.45M -10.88M -10.06M -17.63M -1.18B -17.76M -120M -46.53M -579M -46.75M -45.74M -2.01B | EV / Sales 2024 |
-0.1x | EV / Sales 2025 | -0.56x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| 01/07/16 | Premier Veterinary : Appointment of Broker | PU |
| 28/06/16 | Premier Veterinary : Further Major Agreement Signed in the US | PU |
| 21/06/16 | Premier Veterinary : Director's Dealings | PU |
| 21/06/16 | Premier Veterinary : Block Listing Application and Directors' Dealings | PU |
| 14/06/16 | Premier Veterinary : Director's Dealings | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Dominic Tonner
CEO | Chief Executive Officer | 69 | 27/02/2015 |
Andrew Paull
DFI | Director of Finance/CFO | 52 | 30/11/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Graham Dick
CHM | Chairman | 75 | 01/03/2018 |
Dominic Tonner
BRD | Director/Board Member | 69 | 27/02/2015 |
Rajan Uppal
BRD | Director/Board Member | 63 | 27/02/2015 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 16.53M 21.91M 19.15M 17.71M 31.03M 2.07B 31.26M 210M 81.89M 1.02B 82.27M 80.48M 3.54B | 16.85M 22.33M 19.52M 18.05M 31.63M 2.11B 31.86M 215M 83.47M 1.04B 83.85M 82.04M 3.6B |
| Net income | 3.9M 5.18M 4.52M 4.18M 7.33M 489M 7.38M 49.72M 19.34M 241M 19.43M 19.01M 836M | 3.64M 4.83M 4.22M 3.9M 6.84M 456M 6.89M 46.39M 18.05M 224M 18.14M 17.74M 780M |
| Net Debt | -6.94M -9.2M -8.04M -7.44M -13.03M -869M -13.12M -88.36M -34.38M -427M -34.54M -33.79M -1.48B | -14.69M -19.47M -17.01M -15.74M -27.57M -1.84B -27.78M -187M -72.76M -905M -73.1M -71.51M -3.14B |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















